4//SEC Filing
Pandite Arundathy N. 4
Accession 0000899243-22-001797
CIK 0001680367other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 6:45 PM ET
Size
7.3 KB
Accession
0000899243-22-001797
Insider Transaction Report
Form 4
Pandite Arundathy N.
Chief Medical Officer
Transactions
- Award
Common Stock
2022-01-10+34,738→ 140,904 total - Award
Stock Option (Right to Buy)
2022-01-10+69,475→ 69,475 totalExercise: $7.43Exp: 2032-01-10→ Common Stock (69,475 underlying)
Footnotes (2)
- [F1]Consists of 34,738 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2023, subject to the Reporting Person's continued service to the Issuer.
- [F2]This option represented a right to purchase a total of 69,475 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2023, with the remaining three quarters vesting in equal monthly installments through January 10, 2026, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
Shattuck Labs, Inc.
CIK 0001680367
Entity typeother
Related Parties
1- filerCIK 0001827232
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 6:45 PM ET
- Size
- 7.3 KB